6 employees
Publicly traded (RKV.V) company focused on the development of new cancer treatments based on novel DNA-damage response technologies.
2020
$3.7M
from 1 investors over 1 rounds
Rakovina Therapeutics Inc. raised $3.7M on March 25, 2021
Investors: Red Thread Ventures